公司概覽
業務類別 Medical Devices
業務概覽 NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.
公司地址 Grenville Street, No. 4 The Forum, Second Floor, St. Helier, JEY, JE2 4UF
電話號碼 +44 1534756700
傳真號碼 --
公司網頁 https://www.novocure.com
員工數量 1605
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Michael Puri Chief Human Resources Officer 美元 511.09K 26/02/2026
Dr. Uri Weinberg, M.D.,PhD Chief Medical Officer and Chief Innovation Officer 美元 541.10K 26/02/2026
Mr. Barak Ben-Arye General Counsel -- 26/02/2026
Mr. Francis Leonard Director, President; Chief Executive Officer of the Company and Subsidiary 美元 570.00K 20/04/2026
Mr. Christoph Brackmann Chief Financial Officer and Principal Accounting Officer 美元 541.10K 26/02/2026
Mr. Mukund Paravasthu Chief Operating Officer -- 26/02/2026
 
董事會成員
董事會 職務 更新日期
Mr. Martin J. Madden Independent Director 20/04/2026
Mr. William F. Doyle Executive Chairman of the Board 20/04/2026
Mr. Timothy John Scannell Independent Director 20/04/2026
Mr. Francis Leonard Director, President; Chief Executive Officer of the Company and Subsidiary 20/04/2026
Dr. David T. Hung,M.D. Independent Director 20/04/2026
Ms. Kristin Stafford, C.P.A. Independent Director 20/04/2026
Dr. Allyson J. Ocean, M.D. Independent Director 20/04/2026
Ms. Jeryl L. Hilleman Independent Director 20/04/2026
Mr. William A. Vernon Lead Independent Director 20/04/2026
Mr. Asaf Danziger Director 20/04/2026
Mr. Kinyip Gabriel Leung Independent Director 20/04/2026
 
所屬ETF (更新日期: 02/05/2026 03:58)
代號 名稱 佔比% 持有日期
RBProshares Russell 2000 Dynamic BufferETF0.00003%29/04/2026
AIEQAI Powered Equity ETF<0.000001%24/05/2023
AVSCAvantis US Small Cap Equity ETF<0.000001%08/04/2026
AVUSAvantis US Equity ETF<0.000001%04/03/2026
AVUVAvantis US Small Cap Value ETF<0.000001%11/02/2026
BKSEBNY Mellon US Small Cap Core Equity ETF<0.000001%06/11/2025
BMEDiShares Health Innovation Active ETF<0.000001%19/03/2026
CLSEConvergence Long/Short Equity ETF<0.000001%05/03/2026
CTRUARK Transparency ETF<0.000001%28/07/2022
EESWisdomTree US SmallCap Earnings ETF<0.000001%11/12/2025
EGUSiShares ESG Aware MSCI USA Growth ETF<0.000001%06/03/2026
FTKIFirst Trust Small Cp BuyWrt Inc ETF<0.000001%01/09/2025
FTLSFirst Trust Long/Short Equity ETF<0.000001%02/12/2025
FYXFirst Trust Small Cap Core AlphaDEX® ETF<0.000001%07/10/2025
IWFiShares Russell 1000 Growth ETF<0.000001%05/03/2026
IWPiShares Russell Mid-Cap Growth ETF<0.000001%06/03/2026
IWRiShares Russell Mid-Cap ETF<0.000001%06/03/2026
IYHiShares US Healthcare ETF<0.000001%06/03/2026
IYYiShares Dow Jones US ETF<0.000001%06/03/2026
LFSCF/m Emerald Life Sciences Innovation ETF<0.000001%22/10/2025
  1    2    3   4    5  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.